Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	otic vesicle development	STOX1 SIX1 PROX1	1.32e-05	17	57	3	GO:0071599
GeneOntologyBiologicalProcess	regulation of brown fat cell differentiation	MTOR TRPV4 SIX1	6.95e-05	29	57	3	GO:0090335
GeneOntologyBiologicalProcess	olfactory placode morphogenesis	SIX1 PROX1	7.46e-05	5	57	2	GO:0071699
GeneOntologyBiologicalProcess	olfactory placode development	SIX1 PROX1	7.46e-05	5	57	2	GO:0071698
GeneOntologyBiologicalProcess	olfactory placode formation	SIX1 PROX1	7.46e-05	5	57	2	GO:0030910
GeneOntologyBiologicalProcess	embryonic morphogenesis	HOXA3 CACNA1C NCOA3 COL5A2 PRICKLE1 STOX1 SIX1 PROX1 FOXC2	1.36e-04	713	57	9	GO:0048598
GeneOntologyBiologicalProcess	embryonic organ development	HOXA3 NCOA3 PRICKLE1 POLE STOX1 SIX1 PROX1 FOXC2	1.46e-04	561	57	8	GO:0048568
GeneOntologyCellularComponent	TORC2 complex	MTOR SESN3	2.60e-04	9	57	2	GO:0031932
GeneOntologyCellularComponent	TOR complex	MTOR SESN3	4.74e-04	12	57	2	GO:0038201
Domain	-	NLN THOP1	2.64e-05	3	56	2	1.20.1050.40
Domain	Pept_M3A_M3B	NLN THOP1	2.64e-05	3	56	2	IPR001567
Domain	Peptidase_M3	NLN THOP1	2.64e-05	3	56	2	PF01432
Domain	-	NLN THOP1	2.64e-05	3	56	2	1.10.1370.10
Domain	Neurolysin/TOP_N	NLN THOP1	2.64e-05	3	56	2	IPR024080
Domain	Neurolysin/TOP_dom2	NLN THOP1	2.64e-05	3	56	2	IPR024077
Domain	Cadherin_tail	PCDHGA6 PCDHGA1	5.50e-03	37	56	2	PF15974
Domain	Cadherin_CBD	PCDHGA6 PCDHGA1	5.50e-03	37	56	2	IPR031904
Domain	Cadherin_C	PCDHGA6 PCDHGA1	7.04e-03	42	56	2	IPR032455
Domain	Cadherin_C_2	PCDHGA6 PCDHGA1	7.04e-03	42	56	2	PF16492
Pubmed	Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.	NLN THOP1	2.64e-06	2	57	2	17620116
Pubmed	Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma.	PROX1 FOXC2	2.64e-06	2	57	2	24647631
Pubmed	Defects in vein valve PROX1/FOXC2 antithrombotic pathway in endothelial cells drive the hypercoagulable state induced by trauma and critical illness.	PROX1 FOXC2	2.64e-06	2	57	2	37072887
Pubmed	Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia.	PROX1 FOXC2	2.64e-06	2	57	2	19339011
Pubmed	ESRRG-controlled downregulation of KCNN1 in primary sensory neurons is required for neuropathic pain.	ESRRG KCNN1	2.64e-06	2	57	2	38912580
Pubmed	Swapping the substrate specificities of the neuropeptidases neurolysin and thimet oligopeptidase.	NLN THOP1	2.64e-06	2	57	2	17251185
Pubmed	PROX1 induction by autolysosomal activity stabilizes persister-like state of colon cancer via feedback repression of the NOX1-mTORC1 pathway.	MTOR PROX1	7.91e-06	3	57	2	37224811
Pubmed	Genetic variations in a Sestrin2/Sestrin3/mTOR Axis and development of new-onset diabetes after kidney transplantation.	MTOR SESN3	7.91e-06	3	57	2	37918578
Pubmed	Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis.	PROX1 FOXC2	7.91e-06	3	57	2	31710307
Pubmed	Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation.	PROX1 FOXC2	7.91e-06	3	57	2	32510325
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	HOXA3 CSDE1 NCOA3 ANKEF1 SS18L1 ESRRG MLLT10 SIX1 PROX1	1.20e-05	877	57	9	20211142
Pubmed	Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis.	PROX1 FOXC2	1.58e-05	4	57	2	19825936
Pubmed	Foxo1 deletion promotes the growth of new lymphatic valves.	PROX1 FOXC2	1.58e-05	4	57	2	34263740
Pubmed	Dynamic coupling between TRPV4 and Ca2+-activated SK1/3 and IK1 K+ channels plays a critical role in regulating the K+-secretory BK channel in kidney collecting duct cells.	KCNN1 TRPV4	2.63e-05	5	57	2	28274924
Pubmed	FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor.	MTOR SESN3	2.63e-05	5	57	2	20412774
Pubmed	eNOS Regulates Lymphatic Valve Specification by Controlling β-Catenin Signaling During Embryogenesis in Mice.	PROX1 FOXC2	2.63e-05	5	57	2	37767708
Pubmed	Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase.	NLN NNT	2.63e-05	5	57	2	16497723
Pubmed	Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling.	PROX1 FOXC2	3.94e-05	6	57	2	26079578
Pubmed	Integrative transcriptomic profiling of ncRNAs and mRNAs in developing mouse lens.	PROX1 FOXC2	3.94e-05	6	57	2	38933921
Pubmed	A lymphatic defect causes ocular hypertension and glaucoma in mice.	PROX1 FOXC2	3.94e-05	6	57	2	25202984
Pubmed	Mutation of a nucleosome compaction region disrupts Polycomb-mediated axial patterning.	MLLT10 SIX1	5.51e-05	7	57	2	28280206
Pubmed	Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation.	PROX1 FOXC2	5.51e-05	7	57	2	27214551
Pubmed	Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.	PROX1 FOXC2	5.51e-05	7	57	2	23741013
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HOXA3 NCOA3 ESRRG SIX1 PROX1	7.23e-05	263	57	5	20932939
Pubmed	Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation.	PROX1 FOXC2	7.34e-05	8	57	2	30482854
Pubmed	Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.	PROX1 FOXC2	7.34e-05	8	57	2	32182215
Pubmed	Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.	PROX1 FOXC2	7.34e-05	8	57	2	15465483
Pubmed	Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.	PROX1 FOXC2	9.43e-05	9	57	2	28705793
Pubmed	Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling.	MTOR PROX1	9.43e-05	9	57	2	28974734
Pubmed	A census of human transcription factors: function, expression and evolution.	HOXA3 NCOA3 NKX2-4 ESRRG AKNA SIX1 PROX1 FOXC2	1.12e-04	908	57	8	19274049
Pubmed	FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1.	PROX1 FOXC2	1.18e-04	10	57	2	19398761
Pubmed	Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves.	PROX1 FOXC2	1.18e-04	10	57	2	22012621
Pubmed	GATA2 is required for lymphatic vessel valve development and maintenance.	PROX1 FOXC2	1.44e-04	11	57	2	26214525
Pubmed	Mutations in EPHB4 cause human venous valve aplasia.	PROX1 FOXC2	1.44e-04	11	57	2	34403370
Pubmed	Control of retinoid levels by CYP26B1 is important for lymphatic vascular development in the mouse embryo.	PROX1 FOXC2	1.44e-04	11	57	2	24361262
Pubmed	Differential gene expression in the developing mouse ureter.	COL5A2 FOXC2	1.72e-04	12	57	2	16459152
Pubmed	Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.	PROX1 FOXC2	1.72e-04	12	57	2	15322537
Pubmed	Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels.	PROX1 FOXC2	1.72e-04	12	57	2	33934370
Pubmed	Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid.	HOXA3 SIX1	2.03e-04	13	57	2	12070080
Pubmed	VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance.	PROX1 FOXC2	2.03e-04	13	57	2	31461654
Pubmed	YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling.	PROX1 FOXC2	2.03e-04	13	57	2	33060128
Pubmed	Mechanotransduction activates canonical Wnt/β-catenin signaling to promote lymphatic vascular patterning and the development of lymphatic and lymphovenous valves.	PROX1 FOXC2	2.03e-04	13	57	2	27313318
Pubmed	Complementary Wnt Sources Regulate Lymphatic Vascular Development via PROX1-Dependent Wnt/β-Catenin Signaling.	PROX1 FOXC2	2.03e-04	13	57	2	30332639
Pubmed	The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells.	CACNA1C CNN1	2.03e-04	13	57	2	23946491
Pubmed	Tie1 is required for lymphatic valve and collecting vessel development.	PROX1 FOXC2	2.37e-04	14	57	2	25576926
Pubmed	Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1.	HOXA3 SIX1	2.73e-04	15	57	2	16530750
Pubmed	DNA cloning using in vitro site-specific recombination.	CSDE1 ZNF280D ABLIM3 NNT MTMR10 PRLR FOXC2	3.09e-04	794	57	7	11076863
Pubmed	Fine-tuning of mTOR signaling by the UBE4B-KLHL22 E3 ubiquitin ligase cascade in brain development.	MTOR PROX1	3.12e-04	16	57	2	36440598
Pubmed	Hdac3 regulates lymphovenous and lymphatic valve formation.	PROX1 FOXC2	3.12e-04	16	57	2	29035278
Pubmed	Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.	PROX1 FOXC2	3.12e-04	16	57	2	26027726
Pubmed	Segregated Foxc2, NFATc1 and Connexin expression at normal developing venous valves, and Connexin-specific differences in the valve phenotypes of Cx37, Cx43, and Cx47 knockout mice.	PROX1 FOXC2	3.12e-04	16	57	2	26953188
Pubmed	Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.	PROX1 FOXC2	3.12e-04	16	57	2	28179430
Pubmed	Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development.	PROX1 FOXC2	3.12e-04	16	57	2	26542011
Pubmed	A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis.	SIX1 CNN1	3.12e-04	16	57	2	21364285
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	POLE EIF4A2 NPAP1 CR2 CLDN6	3.15e-04	361	57	5	18976975
Pubmed	Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.	PROX1 FOXC2	3.53e-04	17	57	2	21515254
Pubmed	Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation.	PROX1 FOXC2	3.53e-04	17	57	2	22306086
Pubmed	The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.	PROX1 FOXC2	3.97e-04	18	57	2	16678147
Pubmed	GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126.	PROX1 FOXC2	3.97e-04	18	57	2	31582413
Pubmed	A systematic study of nuclear interactome of C-terminal domain small phosphatase-like 2 using inducible expression system and shotgun proteomics.	NCOA3 ILF3	3.97e-04	18	57	2	26674342
Pubmed	Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.	PROX1 FOXC2	3.97e-04	18	57	2	19686679
Pubmed	Lymph sacs are not required for the initiation of lymph node formation.	CR2 PROX1	4.43e-04	19	57	2	19060331
Pubmed	Chromatin remodeling enzyme Snf2h regulates embryonic lens differentiation and denucleation.	MTOR PROX1	4.43e-04	19	57	2	27246713
Pubmed	Genome-wide association identifies ATOH7 as a major gene determining human optic disc size.	ESRRG SIX1	4.43e-04	19	57	2	20395239
Pubmed	Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp.	CR2 CNN1	4.92e-04	20	57	2	30988302
Pubmed	CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.	CNN1 FOXC2	4.92e-04	20	57	2	33127760
Pubmed	Multiple roles of lymphatic vessels in peripheral lymph node development.	PROX1 FOXC2	4.92e-04	20	57	2	30355615
Pubmed	SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.	ABLIM3 FOXC2	5.43e-04	21	57	2	30021842
Pubmed	Embryonic temporal-spatial delineation of excitatory spinal V3 interneuron diversity.	ESRRG PROX1	5.97e-04	22	57	2	38160393
Pubmed	Gene-environment interaction impacts on heart development and embryo survival.	CACNA1C PROX1	5.97e-04	22	57	2	30787001
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CSDE1 ESRRG ABLIM3	6.03e-04	100	57	3	10048485
Pubmed	Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels.	CNN1 PROX1	6.53e-04	23	57	2	29237738
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	ILF3 HNRNPLL CNN1 PPM1B	7.08e-04	245	57	4	35652658
Pubmed	Etv transcription factors functionally diverge from their upstream FGF signaling in lens development.	MTOR PROX1	7.12e-04	24	57	2	32043969
Pubmed	Overlapping functions of SIX homeoproteins during embryonic myogenesis.	SIX1 CNN1	7.12e-04	24	57	2	37267426
Pubmed	Regulation of planar cell polarity by Smurf ubiquitin ligases.	PRICKLE1 PPM1B	7.73e-04	25	57	2	19379695
Pubmed	mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux.	ILF3 MTOR	7.73e-04	25	57	2	30340022
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	CSDE1 ILF3 HNRNPLL PPM1B	8.58e-04	258	57	4	37794589
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	PRR12 ILF3 POLE SS18L1 CDK19	8.80e-04	453	57	5	29656893
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	CSDE1 DNAJB12 ILF3 EIF4A2 HNRNPLL	9.60e-04	462	57	5	31138677
Pubmed	Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells.	TRPV4 CNN1	1.04e-03	29	57	2	25535917
Pubmed	Identification and analysis of key circRNAs in the mouse embryonic ovary provides insight into primordial follicle development.	NLN PRLR	1.11e-03	30	57	2	38310234
Pubmed	The LIFEdb database in 2006.	CSDE1 ZNF280D ABLIM3 NNT MTMR10 PRLR	1.14e-03	720	57	6	16381901
Pubmed	From ORFeome to biology: a functional genomics pipeline.	CSDE1 ZNF280D ABLIM3 NNT MTMR10 PRLR	1.16e-03	722	57	6	15489336
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	CSDE1 PGGHG MTOR ANKEF1 ESRRG ACBD5 ABLIM3 PRLR	1.17e-03	1293	57	8	15342556
Pubmed	Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling.	MTOR SIX1	1.27e-03	32	57	2	34193412
Pubmed	Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2.	PROX1 FOXC2	1.35e-03	33	57	2	18424556
Pubmed	The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A/4B and affects the stability of CRL4 E3 ligases in colorectal cancer.	NCOA3 ILF3	1.35e-03	33	57	2	32140074
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	NCOA3 ESRRG PROX1	1.38e-03	133	57	3	15604093
Cytoband	10q22.1	DNAJB12 STOX1	1.51e-03	46	57	2	10q22.1
ToppCell	Adult-Mesenchymal-chondrocyte-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL5A2 A2ML1 RHBDD3 ABLIM3	1.31e-06	148	57	5	81a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 SIX1 CNN1	2.45e-06	168	57	5	b220e732eb7b204fc263a9f2e8ddae6bf9fa98f4
ToppCell	Substantia_nigra-Endothelial-MURAL\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 SIX1 CNN1	2.45e-06	168	57	5	271a81c59a9a75bac6107c68fead03e7f35bc192
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HOXA3 CACNA1C COL5A2 ABLIM3 ADAMTSL2	5.73e-06	200	57	5	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 SIX1 CNN1 FOXC2	1.01e-05	105	57	4	73639bfa677c7bb9e5166aa09eabaf1b05bb89a0
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 SIX1 CNN1 FOXC2	1.01e-05	105	57	4	84b639eb44f71d1e12bb7850b9063d80e73cb741
ToppCell	Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)\|Thalamus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 SIX1	2.06e-05	126	57	4	333f83f9ba64d46f22fee328d0a691fd5818bdac
ToppCell	Thalamus-Endothelial-MURAL\|Thalamus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 SIX1	2.06e-05	126	57	4	cf571f36761da3540fb445de89d555cbce8a47ab
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 SIX1 CNN1 FOXC2	2.13e-05	127	57	4	8c972ea21797ee46d6c67e91cfd2e2e2ce016248
ToppCell	Striatum-Neuronal-Inhibitory\|Striatum / BrainAtlas - Mouse McCarroll V32	CR2 ABLIM3 C1orf94 PRLR	4.88e-05	157	57	4	c41ff3fe9de7187575114febfe9bd8733366fb8a
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	HOXA3 CACNA1C CNN1 FOXC2	5.00e-05	158	57	4	8d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL5A2 ADAMTSL2 FOXC2	5.00e-05	158	57	4	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A2 ESRRG ATP13A5 C1orf94	5.25e-05	160	57	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A2 ESRRG ATP13A5 C1orf94	5.25e-05	160	57	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	POLE TRPV4 SIX1 FOXC2	5.38e-05	161	57	4	9703b7e67d9fadb6129cad166bd01be915042e44
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C POLE ATP13A5 PRLR	5.51e-05	162	57	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PCDHGA1 CNN1 FOXC2	5.92e-05	165	57	4	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL5A2 ADAMTSL2 FOXC2	6.20e-05	167	57	4	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	C1orf94 PRLR ADAMTSL2 PROX1	7.11e-05	173	57	4	e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	C1orf94 PRLR ADAMTSL2 PROX1	7.11e-05	173	57	4	f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THOP1 MTOR AKNA TRIM36	7.44e-05	175	57	4	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	Entopeduncular-Endothelial-MURAL\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 CNN1	7.60e-05	176	57	4	b8e52bec78876562a25f0b0de502aa9372b28bd2
ToppCell	wk_08-11-Mesenchymal-Chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PRICKLE1 PCDHGA1 SIX1 FOXC2	7.60e-05	176	57	4	1af28b701c4598ce761f85adbd5d79e4918d265a
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 ATP13A5 CNN1	7.60e-05	176	57	4	10c1f31c27e54b70f58f0b0086ac74dee2ce4197
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	XIRP1 SIX1 CR2 CNN1	7.77e-05	177	57	4	4553ee8cd9c24db6511b09fe49ed11a89e7cde9e
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 PCDHGA6 CNN1 ADAMTSL2	7.94e-05	178	57	4	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 PCDHGA6 CNN1 ADAMTSL2	7.94e-05	178	57	4	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 PCDHGA6 CNN1 ADAMTSL2	7.94e-05	178	57	4	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	COVID-19-kidney-Bcells\|kidney / Disease (COVID-19 only), tissue and cell type	NCOA3 AKNA SESN3 CR2	8.29e-05	180	57	4	5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1C XIRP1 ESRRG CNN1	8.66e-05	182	57	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CACNA1C XIRP1 ESRRG CNN1	9.03e-05	184	57	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C NKX2-4 CNN1 FOXC2	9.41e-05	186	57	4	c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL5A2 PRICKLE1 ADAMTSL2	9.61e-05	187	57	4	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE1 ABLIM3 PROX1 FOXC2	9.81e-05	188	57	4	524a12f433c7b6f33fad36c0716afa06cd3235e9
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE1 ABLIM3 PROX1 FOXC2	9.81e-05	188	57	4	d2610b81b3c7f22977b5e2137b1f61410fc4ef16
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1C PRICKLE1 CNN1 ADAMTSL2	1.00e-04	189	57	4	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNA1C XIRP1 ESRRG CNN1	1.00e-04	189	57	4	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	CACNA1C XIRP1 ESRRG CNN1	1.02e-04	190	57	4	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C XIRP1 SS18L1 CNN1	1.04e-04	191	57	4	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 PRICKLE1 CNN1 ADAMTSL2	1.04e-04	191	57	4	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C XIRP1 CNN1 FOXC2	1.04e-04	191	57	4	8597a8af294f24496c317d995f07eb5dcc25c13c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 PRICKLE1 CNN1 ADAMTSL2	1.04e-04	191	57	4	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C COL5A2 ABLIM3 ADAMTSL2	1.09e-04	193	57	4	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNA1C PRICKLE1 ESRRG CNN1	1.11e-04	194	57	4	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C COL5A2 ABLIM3 ADAMTSL2	1.11e-04	194	57	4	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	21-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	HOXA3 COL5A2 ABLIM3 CNN1	1.11e-04	194	57	4	749dd8113ef260e00facac09de9861d61725124a
ToppCell	LAM-LAM\|LAM / Condition, Lineage and Cell class	CACNA1C ASB10 CNN1 PRLR	1.11e-04	194	57	4	4c6561a64711c72c4ef4a3e67c41d2e8d31fba57
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C XIRP1 SS18L1 CNN1	1.11e-04	194	57	4	b8a130ffae68ffe550bf335460a1ec1035cf8d8d
ToppCell	LAM-LAM-LAM+\|LAM / Condition, Lineage and Cell class	CACNA1C ASB10 CNN1 PRLR	1.11e-04	194	57	4	4ba73a9145ed44896e359f6df9c1f32bbe24a189
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SS18L1 CNN1 FOXC2	1.13e-04	195	57	4	0bdf845939bc4b8cc94f2808aea60f818425b076
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 KRT82 CNN1	1.17e-04	74	57	3	7c7e45cf219b0be5cf0d0e5ea5daeb32284c8ccd
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 KRT82 CNN1	1.17e-04	74	57	3	6183baf43010268f54a6db9332296338f4f74009
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 CNN1 FOXC2	1.17e-04	197	57	4	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C XIRP1 CNN1 FOXC2	1.20e-04	198	57	4	705118a5db366b43ffd3389c60e4cb392ad3f2e6
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	CACNA1C COL5A2 ESRRG ADAMTSL2	1.20e-04	198	57	4	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 CNN1 FOXC2	1.22e-04	199	57	4	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C XIRP1 CNN1 FOXC2	1.22e-04	199	57	4	056a28c36cd58dc695a5ae6f29b62135d6aad819
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 CNN1 FOXC2	1.22e-04	199	57	4	20f760d92c351a1dac4cc0a424c443ea03a179fe
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C XIRP1 CNN1 FOXC2	1.22e-04	199	57	4	ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 CNN1 FOXC2	1.24e-04	200	57	4	38190e4b32f7469df1da7d130bca6d7b12a3dd06
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3\|Control_saline / Treatment groups by lineage, cell group, cell type	COL5A2 ASB10 CNN1 FOXC2	1.24e-04	200	57	4	b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 PRICKLE1 ADAMTSL2	1.24e-04	200	57	4	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm\|1m / Sample Type, Dataset, Time_group, and Cell type.	HOXA3 LCA5L ABLIM3 CNN1	1.24e-04	200	57	4	c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL5A2 PRICKLE1 ADAMTSL2	1.24e-04	200	57	4	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.03e-04	89	57	3	442931182f7eb87f16c19774607eb14b44cd7ec7
ToppCell	Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.03e-04	89	57	3	05ba2c31bb4bd8c7ad4bcbbefe818c08136101b2
ToppCell	Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)\|Thalamus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.03e-04	89	57	3	2c19e2dc979d0f86539a044ae49f126caff50fbb
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.09e-04	90	57	3	d809ebc50917aaf13e693b21c8faa399103e7abe
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.09e-04	90	57	3	6b94b1b05d45ecdc2ac9d5445d244dac96d60c22
ToppCell	Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.53e-04	96	57	3	cd0b9812727cad937cf840360a87a2382e570d39
ToppCell	Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.53e-04	96	57	3	f31bed26ed9bcaf82d443de304372991136b11e7
ToppCell	Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	XIRP1 ASB10 CNN1	2.53e-04	96	57	3	31ed9e073e30d740b46c8b3f01ba0de94a701995
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 SIX1 CNN1	2.77e-04	99	57	3	0e2f6ba2261cc289f8f4aec5aac3051f6321e041
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XIRP1 SIX1 CNN1	2.77e-04	99	57	3	ce9d6d9b82bdc1ebb58b0b6e04abfb022dd1de88
Disease	temporal lobe epilepsy (implicated_via_orthology)	PRICKLE1 MTOR	1.26e-04	9	56	2	DOID:3328 (implicated_via_orthology)
Disease	childhood trauma measurement, alcohol consumption measurement	DNAJB12 PCDHGA6 PCDHGA1	3.38e-04	71	56	3	EFO_0007878, EFO_0007979
Disease	Schwartz-Jampel Syndrome, Type 1	TRPV4 ADAMTSL2	4.17e-04	16	56	2	C4551479
Disease	Spondyloepiphyseal Dysplasia	TRPV4 ADAMTSL2	4.17e-04	16	56	2	C0038015
Disease	Abnormal behavior	PRR12 TRPV4	4.17e-04	16	56	2	C0233514
Disease	Schwartz-Jampel Syndrome	TRPV4 ADAMTSL2	4.17e-04	16	56	2	C0036391
Disease	Melnick-Needles Syndrome	TRPV4 ADAMTSL2	4.17e-04	16	56	2	C0025237
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	TRPV4 ADAMTSL2	4.17e-04	16	56	2	C3541456
Disease	Van Buchem disease	TRPV4 ADAMTSL2	4.72e-04	17	56	2	C0432272
Disease	Dyschondroplasias	TRPV4 ADAMTSL2	5.93e-04	19	56	2	C0013366
Disease	Osteochondrodysplasias	TRPV4 ADAMTSL2	5.93e-04	19	56	2	C0029422
Disease	Multiple Epiphyseal Dysplasia	TRPV4 ADAMTSL2	6.58e-04	20	56	2	C0026760
Disease	myeloperoxidase (MPO)-DNA complex measurement	CDK19 ATP13A5	7.98e-04	22	56	2	EFO_0011039
Disease	Sarcosine measurement	PCDHGA6 PCDHGA1	8.72e-04	23	56	2	EFO_0021668
Disease	mental development measurement	PCDHGA6 PCDHGA1	1.03e-03	25	56	2	EFO_0008230
Disease	cancer (implicated_via_orthology)	MTOR POLE ESRRG PROX1	1.69e-03	268	56	4	DOID:162 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
DTGLSHYQGGPTLSM	ZNF280D	151	Q6N043
HTAGYEMSLNGSPRS	ABLIM3	556	O94929
YMHTGNSSTPRGEGG	ATP13A5	776	Q4VNC0
GANSGGPVMPSDYQH	CDK19	446	Q9BWU1
PSQGGSSLGMAQRHN	CSRNP2	86	Q9H175
YLGGHSSQPMENSGF	ACBD5	336	Q5T8D3
CGVSANTMDYGGHTP	ASB10	316	Q8WXI3
HRSPEYSTAMGAGGG	A2ML1	696	A8K2U0
GNTPLHYAAMGGFAD	ANKEF1	251	Q9NU02
NGHNGYPNGTSAALR	CSDE1	11	O75534
GPLMHSPYFSSSGNG	C1orf94	581	Q6P1W5
QASSSYMHGGNPSGS	HNRNPLL	321	Q8WVV9
QASGGGLASMPGSHF	PCDHGA6	726	Q9Y5G7
QFPHGAMGSYCNGGL	NKX2-4	101	Q9H2Z4
PGAGGYLNSMHSLVN	HOXA3	271	O43365
THLPHAASGAMDYGG	HOXA3	386	O43365
LGQSRMYFNASGPHH	MTMR10	711	Q9NXD2
MNSHSYNGSVGRPLG	KCNN1	1	Q92952
MGFVPHNGSLYGQAS	ADAMTSL2	361	Q86TH1
GGPANAGNMRYSHST	LCA5L	541	O95447
YSGHPEQYSAGMGRS	FOXC2	41	Q99958
MSYHSFQPGSRCGSQ	KRT82	1	Q9NSB4
NQMPSLGALYSAEHG	POLE	1521	Q07864
YNGAGGDTHRAMLPS	PGGHG	46	Q32M88
HATSDYGLQNPGMNR	PRICKLE1	736	Q96MT3
QGSNYGSPRPAHANM	CACNA1C	16	Q13936
NHTGGNIARFSPGMS	CR2	861	P20023
GSYSSTMNGHQNGLD	ESRRG	66	P62508
GFPSSNVHVYSNGRM	DNAJB12	211	Q9NXW2
SSQGGYGRNADHSMN	ILF3	876	Q12906
GNTSPMALGHGQARG	AKNA	156	Q7Z591
MNRGSQFAYGDHQSP	COL5A2	1366	P05997
MSGGSADYNREHGGP	EIF4A2	1	Q14240
QASGGGLASMPGSHF	PCDHGA1	726	Q9Y5H4
YSSHQGLMGFGTSPS	MTOR	336	P42345
MGGHLYPSTTSQGLA	NNT	546	Q13423
SHTLYPAFALMGSGG	TRIM36	696	Q9NQ86
YSGSAMQEGLSPNHL	PROX1	571	Q92786
NNNYGLNMSSPPHGS	NCOA3	456	Q9Y6Q9
GNMGHARSSNYSLPG	SIX1	236	Q15475
HGAGNGLRYGLSSMQ	PPM1B	16	O75688
SMYHRQGGVPGTFAN	RNF220	71	Q5VTB9
CGGSYPSMGHRANLA	PRR12	316	Q9ULL5
YMGLPGSGNTLHSDS	NPAP1	851	Q9NZP6
SGSSLSQAPSHMYGN	MLLT10	631	P55197
PSGGSQGPSHYMARY	CLDN6	186	P56747
MSSAHFNRGPAYGLS	CNN1	1	P51911
GYSHAGPASQGVPMQ	SS18L1	151	O75177
TNMPATFGHLAGGYD	NLN	616	Q9BYT8
GLSSAAGSCGYMPVH	RHBDD3	111	Q9Y3P4
MNRGGGSPSAAANYL	SESN3	1	P58005
MLPGHSQYSFTGGSQ	STOX1	751	Q6ZVD7
GGPNSCHFGKQYTSM	PRLR	81	P16471
GHTPYSSMLNQGLGV	SLC30A6	416	Q6NXT4
MHPTRYILAGGNSSG	WDR76	601	Q9H967
GTNMPATFGHLAGGY	THOP1	591	P52888
ELQTGPGSSQHYGAM	XIRP1	1751	Q702N8
DSMGNPRCDGHQQGY	TRPV4	846	Q9HBA0